PUBLISHER: IMARC | PRODUCT CODE: 1722660
PUBLISHER: IMARC | PRODUCT CODE: 1722660
The global whole slide imaging market size reached USD 849.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,064.3 Million by 2033, exhibiting a growth rate (CAGR) of 9.85% during 2025-2033.
Whole slide imaging (WSI) is scanning glass slides used to produce high-resolution and precise digital images of tissue sections. It comprises a focusing unit, camera, illumination systems, scanners, viewers, image management system, and microscopic optical components. WSI utilizes a specialized scanner to digitize glass slides and generate large digital images that are analyzed, stored, and shared through the virtual slide viewer. It is widely used in immunohistochemistry, telepathology, hematopathology, and cytopathology. WSI assists in improving accuracy, speed of analysis, increasing productivity, reducing errors, and providing reliable and convenient results. As a result, it is widely used across academic and research institutes, biotechnology and pharmaceutical companies, and hospitals and clinics.
The significant growth in the healthcare industry and the rising focus on patient safety across the globe are the prime factors creating a positive outlook for the market. Additionally, the rising prevalence of cancer due to the changing lifestyles, genetic mutation, and increasing smoking and alcohol habits is favoring the market growth. In line with this, WSI is extensively used in diagnostic procedures for suspected skin, lungs, and breast cancer, which is further providing an impetus to the market growth. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) to assist in various diseases and diagnoses and provide precision medicine delivery, are providing a considerable boost to the market growth. In line with this, the widespread adoption of whole slide imaging in immunohistochemistry (IHC) to observe protein expression in tissue samples and detect antigens in the cells is positively impacting the market growth. Other factors, such as the increasing product demand in drug discovery and extensive research and development (R&D) activities, are anticipated to drive the market growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3DHISTECH Ltd., Beckman Coulter Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, General Electric Company, Hamamatsu Photonics KK, Huron Technologies Internationa, Inspirata Inc., Koninklijke Philips N.V., Mikroscan Technologies Inc., Olympus Corporation, Perkinelmer Inc. and Visiopharm A/S.